- Home
- CLPT vs PEPG Comparison
CLPT vs PEPG Comparison
Compare CLPT & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- PEPG
- Stock Information
- Founded
- CLPT 1998
- PEPG 2018
- Country
- CLPT United States
- PEPG United States
- Employees
- CLPT N/A
- PEPG N/A
- Industry
- CLPT Medical/Dental Instruments
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- PEPG Health Care
- Exchange
- CLPT Nasdaq
- PEPG Nasdaq
- Market Cap
- CLPT 318.4M
- PEPG 317.6M
- IPO Year
- CLPT N/A
- PEPG 2022
- Fundamental
- Price
- CLPT $27.01
- PEPG $5.00
- Analyst Decision
- CLPT Strong Buy
- PEPG Strong Buy
- Analyst Count
- CLPT 3
- PEPG 6
- Target Price
- CLPT $27.67
- PEPG $8.17
- AVG Volume (30 Days)
- CLPT 1.5M
- PEPG 9.5M
- Earning Date
- CLPT 11-06-2025
- PEPG 11-06-2025
- Dividend Yield
- CLPT N/A
- PEPG N/A
- EPS Growth
- CLPT N/A
- PEPG N/A
- EPS
- CLPT N/A
- PEPG N/A
- Revenue
- CLPT $33,593,000.00
- PEPG N/A
- Revenue This Year
- CLPT $22.34
- PEPG N/A
- Revenue Next Year
- CLPT $25.50
- PEPG N/A
- P/E Ratio
- CLPT N/A
- PEPG N/A
- Revenue Growth
- CLPT 19.68
- PEPG N/A
- 52 Week Low
- CLPT $9.76
- PEPG $0.88
- 52 Week High
- CLPT $28.80
- PEPG $9.94
- Technical
- Relative Strength Index (RSI)
- CLPT 84.97
- PEPG 71.59
- Support Level
- CLPT $20.16
- PEPG $4.33
- Resistance Level
- CLPT $28.80
- PEPG $5.36
- Average True Range (ATR)
- CLPT 1.93
- PEPG 0.52
- MACD
- CLPT 1.29
- PEPG 0.21
- Stochastic Oscillator
- CLPT 87.87
- PEPG 69.60
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.